[Federal Register Volume 69, Number 211 (Tuesday, November 2, 2004)]
[Notices]
[Pages 63541-63546]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-24390]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

Agency for Toxic Substances and Disease Registry


Public Health Conference Support Grant Program

    Announcement Type: New.
    Funding Opportunity Number: 05002.
    Catalog of Federal Domestic Assistance Number: The Centers for 
Disease Control and Prevention (CDC) Catalog of Federal Domestic 
Assistance (CFDA) number is 93.283. The Agency for Toxic Substances and 
Disease Registry (ATSDR) Catalog of Federal Domestic Assistance (CFDA) 
number is 93.161.

DATES: Key Dates:
    Letter of Intent (LOI) Deadline: Cycle A: November 24, 2004; Cycle 
B: February 3, 2005.
    Application Deadline: Cycle A: January 14, 2005; Cycle B: April 6, 
2005.

I. Funding Opportunity Description

    Authority: The Centers for Disease Control and Prevention (CDC) 
program is authorized under section 317(k)(2) of the Public Health 
Service Act, [42 U.S.C. 247b(k)(2)] as amended. The Agency for Toxic 
Substances and Disease Registry (ATSDR) program is authorized under 
sections 104 (i)(14) and (15) of the Comprehensive Environmental 
Response, Compensation, and Liability Act of 1980 (CERCLA), as 
amended by the Superfund Amendments and Reauthorization Act of 1986 
(SARA), [42 U.S.C. 9604(i)(14) and (15)].

    Purpose: The Centers for Disease Control and Prevention (CDC) and 
the Agency for Toxic Substances and Disease Registry (ATSDR) announce 
the pending availability of appropriated fiscal year (FY) 2005 funds 
for a grant program for Public Health Conference Support. This program 
addresses the ``Healthy People 2010'' focus areas of Disability and 
Secondary Conditions, Educational and Community-Based Programs, 
Environmental Health, Injury and Violence Prevention, Maternal, Infant 
and Child Health, Vision and Newborn Hearing (specifically newborn 
screening, evaluation and intervention), Public Health Infrastructure, 
Tuberculosis, Respiratory Diseases, and Sexually Transmitted Diseases 
(STD).
    Human Immunodeficiency Virus (HIV) Conferences and HIV subject 
matter are covered under another program and are not permitted under 
this announcement.
    The purpose of conference support funding is to provide partial 
support for specific non-Federal conferences (not a series) in the 
areas of health promotion and disease prevention information and 
education programs, and applied research. A series is the exact same 
conference conducted more than one time during the project period. An 
applicant can apply for funding for more than one different conference 
during the project period.
    Congress has required that there will be active participation by 
CDC/ATSDR in the development and approval of the conference agenda to 
make sure there are no subjects that would embarrass the Government or 
be an improper use of funds including portions that are not funded by 
CDC/ATSDR. CDC/ATSDR funds will be expended only for approved portions 
of the conference.
    The mission of CDC is to promote health and improve the quality of 
life by preventing and controlling disease, injury, and disability.
    Through the support of conferences and meetings (not a series) in 
the areas of public health research, education, prevention research in 
program and policy development in managed care and prevention 
application, CDC is meeting its overall goal of dissemination and 
implementation of new cost-effective intervention strategies.
    The mission of ATSDR is to prevent both exposure and adverse human 
health effects that diminish the quality of life associated with 
exposure to hazardous substances from waste sites, unplanned releases, 
and other sources of pollution present in the environment.
    ATSDR's systematic approaches are needed for linking applicable 
resources in public health with individuals and organizations involved 
in the practice of applying such research. Mechanisms are also needed 
to shorten the time frame between the development of disease prevention 
and health promotion techniques and their practical application. ATSDR 
believes that conferences and similar meetings (not a series) that 
permit individuals to engage in hazardous substances and environmental 
health research, education, and application (related to actual and/or 
potential human exposure to toxic substances) to interact, are critical 
for the development and implementation of effective programs to prevent 
adverse health effects from hazardous substances.
    Measurable outcomes of the program will be in alignment with one 
(or more) of the following performance goal(s):
    Agency for Toxic Substances and Disease Registry (ATSDR):
    <bullet> Prevent ongoing and future exposures and resultant health 
effects from hazardous waste sites and releases;

[[Page 63542]]

    <bullet> Determine human health effects associated with exposures 
to superfund-related priority hazardous substances;
    <bullet> Mitigate the risks of human effects at toxic waste sites 
with documented exposures;
    <bullet> Build and enhance effective partnerships;
    <bullet> Promote effective and efficient agency management.
    National Center of Birth Defects and Developmental Disabilities 
(NCBDDD):
    <bullet> Increase the consumption of folic acid among women of 
reproductive age to prevent serious birth defects;
    <bullet> Decrease the number of women drinking during pregnancy;
    <bullet> Monitoring speech, language, and other developmental 
outcomes of infants with hearing loss;
    <bullet> Improve the data on the prevalence of birth defects and 
developmental disabilities;
    <bullet> Find causes and risk factors for birth defects and 
developmental disabilities in order to develop prevention strategies;
    <bullet> Monitor, characterize, and improve the health status of 
Americans with disabilities;
    <bullet> Increase knowledge by developing and implementing 
evidence-based approaches on adverse consequences of hereditary 
conditions including blood disorders.
    National Center for Environmental Health Services (NCEH):
    <bullet> Determine Human Health effects associated with 
environmental exposures and hazards;
    <bullet> Ensure laboratory standards are maintained in all 
certified labs for the following tests associated with health effects: 
Lipids, Newborn Screening, Blood Lead, and Urinary Iodine;
    <bullet> Ensure that 100 percent of chemical stockpiles housed at 
federal facilities are disposed of without any serious injuries or 
deaths from chemical agents;
    <bullet> Build and enhance effectively partnerships to improve 
environmental health capacity;
    <bullet> Provide assistance to 20 partners;
    <bullet> Promote effective and efficient NCEH management.
    National Center for (HIV), STD, and Tuberculosis (TB) Prevention 
(NCHSTP):
    <bullet> Strengthen the capacity of our STD, TB, and HIV prevention 
partners nationwide to monitor STD, TB, and HIV epidemic;
    <bullet> Develop and implement effective STD, TB, and HIV 
prevention interventions, and evaluate prevention programs.
    National Center for Injury Prevention and Control (NCIPC):
    <bullet> Reduce the risk of youth violence;
    <bullet> Reduce violence against women;
    <bullet> Enhance the capacity of states to implement effective rape 
prevention and education programs;
    <bullet> Reduce the number and severity of head injuries by 
increasing bicycle helmet use;
    <bullet> Improve the timelines and quality of data used to 
determine the medical and social impact of traumatic brain injury;
    <bullet> Reduce the incidence of residential fire-related injuries 
and deaths by increasing functional smoke alarms on every habitable 
floor;
    <bullet> Increase external input on the research priorities, 
policies, and procedures related to the extramural research supported 
by CDC;
    <bullet> Provide online access to injury prevention data;
    <bullet> Improve the uniformity, quality, and accessibility of 
emergency department data for public health surveillance in several 
states; ultimately developing the capacity to improve data in all 
states through development of guidelines, recommendations, or technical 
assistance.
    Public Health Practice Program Office (PHPPO):
    <bullet> Continue efforts to protect the safety and security of 
laboratorians regarding the handling and processing of biological 
agents;
    <bullet> Enhance the capacity (including laboratory) of CDC and 
state and local health departments to prepare for and respond to a 
biological and chemical terrorism event through rapid and accurate 
detection means, including the investigation and communication of 
critical information;
    <bullet> Continue efforts to protect the health and safety of first 
responders during biological and chemical terrorism events.
    <bullet> Implement training programs to provide an effective 
workforce for U.S. health departments and laboratories and ministries 
of health in developing countries;
    <bullet> Ensure state and local health departments will monitor the 
health of its communities, and assist in the detection of emerging 
public health problems;
    <bullet> Conduct research to identify and evaluate community-based 
prevention interventions;
    <bullet> Strengthen the ability to obtain and disseminate 
extramural research findings to partners, public health practitioners, 
managed care organizations, and the public through a prevention 
research communications program;
    <bullet> Increase input from the external scientific community on 
extramural prevention research and strengthen the scope and nature of 
extramural public health research programs;
    <bullet> Disseminate research findings and other relevant 
information from prevention research programs to public health 
practitioners, managed-care organizations, and consumer groups;
    <bullet> Increase collaborations focusing on innovative 
intervention methods.
    This announcement is only for non-research activities supported by 
CDC/ATSDR. If research is proposed, the application will not be 
reviewed. For the definition of research, please see the CDC Web site 
at the following Internet address: http://www.cdc.gov/od/ads/opspoll1.htm.
    Activities: In conducting activities to achieve the purpose of this 
program, the recipient will be responsible for the following 
activities:
    <bullet> The conference organizer(s) may use CDC's/ATSDR's name 
only in factual publicity for the conference. CDC/ATSDR involvement in 
the conference does not necessarily indicate support for the 
organizer's general policies, activities, products, or the content of 
speakers' presentations.
    <bullet> Any national conference co-sponsored under this 
announcement shall be held in facilities that are fully accessible to 
the public as required by the Americans with Disabilities Act 
Accessibility Guidelines (ADAAG)(Does not apply to international 
conferences). Accessibility under ADAAG addresses accommodations for 
persons with sensory impairments as well as persons with physical 
disabilities or mobility limitations.
    <bullet> Manage all activities related to program content (e.g., 
objectives, topics, attendees, session design, workshops, special 
exhibits, speaker's fees, agenda composition, and printing). Many of 
these items may be developed in concert with assigned CDC or ATSDR 
project personnel.
    <bullet> Provide draft copies of the agenda and proposed ancillary 
activities to CDC or ATSDR for approval. All but ten percent of the 
total funds awarded for the proposed conference will be initially 
restricted pending approval of a full, final agenda by CDC or ATSDR. 
The remaining 90 percent of funds will be released by letter to the 
grantee upon the approval of the final agenda. Because conference 
support by CDC and ATSDR creates the appearance of CDC co-sponsorship, 
there will be active participation by CDC or ATSDR in the development 
and approval of those portions of the agenda supported by CDC funds. 
CDC funds will not be expended for non-approved portions of meetings. 
In addition, CDC will reserve

[[Page 63543]]

the right to approve or reject the content of the full agenda, press 
events, promotional materials (including press releases), speaker 
selection, and site selection. CDC and ATSDR reserve the right to 
terminate co-sponsorship if it does not concur with the final agenda.
    <bullet> Determine and manage all promotional activities (e.g., 
title, logo, announcements, mailers, press, etc.). CDC or ATSDR must 
review and approve any materials with reference to CDC or ATSDR 
involvement or support.
    <bullet> Manage all registration processes with participants, 
invitees, and registrants (e.g., travel, reservations, correspondence, 
conference materials and handouts, badges, registration procedures, 
etc.).
    <bullet> Plan, negotiate, and manage conference site arrangements, 
including all audio-visual needs.

II. Award Information

    Type of Award: Grant.
    Fiscal Year Funds: FY 2005.
    Approximate Total Funding: Approximately $600,000 may be available 
from CDC in FY 2005 to fund approximately 30 to 55 awards.
    Approximately $25,000 is available from ATSDR in FY 2005 to fund 
approximately three to five awards.
    Approximate Number of Awards: 60.
    Approximate Average of Awards: It is expected that the average 
award will be $20,000 for CDC and $8,000 for ATSDR.
    Floor of Award Range: None.
    Ceiling of Award Range: None.
    Anticipated Award Date: On or about sixty days before the date of 
the conference.
    Budget Period Length: 12 month budget period for each cycle.
    Project Period Length: 12 month project period for each cycle.

III. Eligibility Information

III.1. Eligible Applicants

    Applications may be submitted for CDC support by public and private 
nonprofit organizations and by governments and their bona fide 
agencies, such as:
    <bullet> Public nonprofit organizations.
    <bullet> Private nonprofit organizations.
    <bullet> Faith-Based organizations.
    <bullet> Universities and Colleges.
    <bullet> Voluntary associations.
    <bullet> Foundations and civic groups.
    <bullet> Scientific or professional associations.
    <bullet> Federally recognized Indian tribal governments.
    Applications for ATSDR support in addition to the above may be 
submitted by the official public health agencies of the States or their 
bona fide agents. This includes:
    <bullet> The District of Columbia, the Commonwealth of Puerto Rico, 
the Virgin Islands, the Commonwealth of the Northern Marianna Islands, 
American Samoa, Guam, the Federated States of Micronesia, the Republic 
of the Marshall Islands, and the Republic of Palau.
    <bullet> Political subdivisions of States (in consultation with 
States).
    A bona fide agent is an agency/organization identified by the state 
as eligible to submit an application under the state eligibility in 
lieu of a state application. If you are applying as a bona fide agent 
of a state or local government, you must provide a letter from the 
state or local government as documentation of your status. Place this 
documentation behind the first page of your application form.
    Also eligible are nationally and internationally recognized 
associations of health professionals and other chartered organizations 
generally recognized as demonstrating a need for information to protect 
the public from health effects of exposure to hazardous substances.
    Only conferences planned for May 1, 2005 through September 30, 2006 
are eligible to apply under this announcement.

III.2 Cost Sharing or Matching

    Matching funds are not required for this program.

III.3 Other

    CDC will accept and review applications with budgets greater than 
the ceiling of the award range. No ceiling limit has been established 
for Conference Support budgets. Refer to II Award Information for award 
ranges.

Special Requirements

    <bullet> Late applications will be considered non-responsive. See 
section ``IV.3. Submission Dates and Times'' for more information on 
deadlines.
    <bullet> Applicants who do not submit a LOI will not be eligible to 
submit an application for review or funding.
    <bullet> Note: Title 2 of the United States Code Section 1611 
states that an organization described in Section 501(c)(4) of the 
Internal Revenue Code that engages in lobbying activities is not 
eligible to receive Federal funds constituting an award, grant, or 
loan.

IV. Application and Submission Information

IV.1. To Request Application Package

    To apply for this funding opportunity use application form PHS 
5161-1 (OMB Number 0937-0189). Application forms and instructions are 
available on the CDC Web site, at the following Internet address: 
http://www.cdc.gov/od/pgo/forminfo.htm.
    If you do not have access to the Internet, or if you have 
difficulty accessing the forms on-line, you may contact the CDC 
Procurement and Grants Office Technical Information Management Section 
(PGO-TIM) staff at: 770-488-2700. Application forms can be mailed to 
you.

IV.2. Content and Form of Submission

    Letter of Intent (LOI):
    A Letter of Intent is required for this Program Announcement. The 
LOI will not be evaluated or scored. Your LOI will be used to estimate 
the potential reviewer workload and to avoid conflicts of interest 
during the review. You must submit an original and two copies. If you 
do not submit a LOI, you will not be allowed to submit an application.
    Your LOI must be written in the following format:
    <bullet> Maximum number of pages: two to three typewritten pages.
    <bullet> Font size: 12-point unreduced.
    <bullet> Single spaced.
    <bullet> Paper size: 8.5 by 11 inches.
    <bullet> Page margin size: One inch.
    <bullet> Printed only on one side of page.
    <bullet> Written in plain language, avoid jargon.
    Your LOI must contain the following information:
    <bullet> The name of the organization.
    <bullet> Primary contact person's name.
    <bullet> Mailing address.
    <bullet> Telephone number and, if available, fax and e-mail.
    <bullet> Title of the proposed conference-include the term 
``conference,'' ``symposium,'' or similar designation.
    <bullet> Date(s) of conference-inclusive dates (not a series) of 
the conference. A series would be the exact same conference conducted 
more than one time.
    <bullet> Location of city, state, and physical facilities required 
for the conduct of the meeting.
    <bullet> Main Conference topics (no more than 2). See attachment 
II.
    <bullet> Total conference cost and total requested from CDC (must 
be less than 100 percent).
    <bullet> Intended audience, approximate number, and profession of 
persons expected to attend.
    <bullet> Justification for the conference.
    This information must also be included in a summary page sent with 
the application.
    Application: You must submit a project narrative with your 
application forms. The narrative must be submitted in the following 
format:

[[Page 63544]]

    <bullet> Maximum number of pages: 12 pages. If your narrative 
exceeds the page limit, only the first pages, which are within the page 
limit, will be reviewed.
    <bullet> Font size: 12 point unreduced.
    <bullet> Double spaced.
    <bullet> Paper size: 8.5 by 11 inches.
    <bullet> Page margin size: One inch.
    <bullet> Printed only on one side of page.
    <bullet> Clearly numbered pages.
    <bullet> A complete index to the application and appendices.
    <bullet> Held together only by rubber bands or metal clips; not 
bound in any other way.
    Your narrative should address activities to be conducted during the 
entire project period:
    <bullet> A brief background of the organization--include the 
organizational history, purpose, and previous experience related to the 
proposed conference topic.
    <bullet> A clear statement of the need for and purpose of the 
conference. This statement should also describe any problems the 
conference will address or seek to solve, and the action items or 
resolutions it may stimulate.
    <bullet> An elaboration on the conference objectives and target 
audience. A list should be included of the principal areas or topics to 
be addressed. A proposed or final agenda must be included.
    <bullet> A clear description of the evaluation plan and how it will 
assess the accomplishments of the conference objectives. A sample of 
the evaluation instrument that will be used must be included and a 
step-by-step schedule and detailed operation plan of major conference 
planning activities necessary to attain specified objectives.
    <bullet> Budget plan and justification--A clearly justified budget 
narrative that is consistent with the purpose, objectives, and 
operation plan of the conference. It should include the share requested 
from this grant as well as those funds from other sources, including 
organizations, institutions, conference income, and/or registration 
fees. (The 12 page limit does not include the budget.)
    Additional information may be included in the application 
appendices. The appendices will not be counted toward the narrative 
page limit. This additional information includes:
    <bullet> Biographical sketches are required for the individuals 
responsible for planning and implementing the conference. Experience 
and training related to conference planning and implementation as it 
relates to the proposed topic should be noted.
    <bullet> Letters of endorsement or support--Letters of endorsement 
or support for the sponsoring organization and its capability to 
perform the proposed conference activity.
    You are required to have a Dun and Bradstreet Data Universal 
Numbering System (DUNS) number to apply for a grant or cooperative 
agreement from the Federal government. The DUNS number is a nine-digit 
identification number, which uniquely identifies business entities. 
Obtaining a DUNS number is easy and there is no charge. To obtain a 
DUNS number, access www.dunandbradstreet.com or call 1-866-705-5711.
    For more information, see the CDC Web site at: http://www.cdc.gov/od/pgo/funding/pubcommt.htm.
    Please include your DUNS number in your application cover letter.

IV.3. Submission Dates and Times

    Deadline:
    LOI and application deadlines have now been imposed for all 
conference support grants, and dates should be strictly followed by 
applicants to ensure that their LOIs and applications are received in a 
timely manner. There will be two conference support reviews this year. 
If your conference dates fall between May 1, 2005, to April 30, 2006, 
you should apply under Cycle A under this announcement.
    If your conference dates fall between August 1, 2005, to September 
30, 2006, you should apply under Cycle B under this announcement.
    Letter of Intent Due Dates:

Cycle A: November 24, 2004.
For conferences May 1, 2005-April 30, 2006.
Cycle B: February 3, 2005.
For conferences August 1, 2005-September 30, 2006.
    Letter of Intent (LOI) Submission:

    On or before November 24, 2004, and February 3, 2005, submit an 
original and two signed copies of the LOI to: Technical Information 
Management PA<greek-i>05002, Procurement and Grants Office, Centers for 
Disease Control and Prevention, 2920 Brandywine Road, Atlanta, GA 
30341-4146.
    Applicants who do not submit an LOI will not be eligible to submit 
an application for review or funding.
    Application Due Dates: Earliest Possible Award Dates:CYCLE A: 
January 14, 2005, April 2005. CYCLE B: April 6, 2005, June 2005.
    Submit application to:
    Technical Information Management PA<greek-i>05002, Procurement and 
Grants Office, Centers for Disease Control and Prevention, 2920 
Brandywine Road, Atlanta, GA 30341-4146.
    Applications may not be submitted electronically. Applications 
received that were not preceded by a LOI will not be reviewed or 
funded.
    Explanation of Deadlines: LOIs and Applications must be received in 
the CDC Procurement and Grants Office by 4 p.m. Eastern Time on the 
deadline date. If you submit your LOI or application by the United 
States Postal Service or commercial delivery service, you must ensure 
that the carrier will be able to guarantee delivery by the closing date 
and time. If CDC receives your submission after closing due to: (1) 
Carrier error, when the carrier accepted the package with a guarantee 
for delivery by the closing date and time, or (2) significant weather 
delays or natural disasters, you will be given the opportunity to 
submit documentation of the carriers guarantee. If the documentation 
verifies a carrier problem, CDC will consider the submission as having 
been received by the deadline.
    This announcement is the definitive guide on LOI and application 
content, submission address, and deadline. It supersedes information 
provided in the application instructions. If your submission does not 
meet the deadline above, it will not be eligible for review, and will 
be discarded. You will be notified that you did not meet the submission 
requirements.
    CDC will not notify you upon receipt of your submission. If you 
have a question about the receipt of your LOI or application, first 
contact your courier. If you still have a question, contact the PGO-TIM 
staff at: 770-488-2700. Before calling, please wait two to three days 
after the submission deadline. This will allow time for submissions to 
be processed and logged.

IV.4. Intergovernmental Review of Applications

    Your application is subject to Intergovernmental Review of Federal 
Programs, as governed by Executive Order (EO) 12372. This order sets up 
a system for state and local governmental review of proposed federal 
assistance applications. You should contact your state single point of 
contact (SPOC) as early as possible to alert the SPOC to prospective 
applications, and to receive instructions on your state's process. 
Click on the following link to get the current SPOC list: http://www.whitehouse.gov/omb/grants/spoc.html.

IV.5. Funding Restrictions

    Restrictions, which must be taken into account while writing your 
budget, are as follows:
    <bullet> Funds may be used for direct cost expenditures: Salaries; 
speaker fees (for

[[Page 63545]]

services rendered); rental of necessary conference--related equipment; 
registration fees; and transportation costs (not to exceed economy 
class fare) for non-Federal individuals.
    <bullet> Funds may be used for only those parts of the conference 
specifically supported by CDC or ATSDR as documented in the grant 
award.
    <bullet> Funds may not be used for the purchase of equipment; 
payments of honoraria (different from speaker fees in that it would be 
for someone to draw attention to the conference such as a celebrity and 
who usually has no expertise in the public health area); alterations or 
renovations; organizational dues; support entertainment or personal 
expenses; food or snack breaks; cost of travel and payment of a Federal 
employee or per diem or expenses for local participants (other than 
local mileage). Travel for Federal employees will be supported by CDC/
ATSDR. Travel for other Federal employees will be supported by the 
employees' Federal agency.
    <bullet> Funds may not be used for reimbursement of indirect costs.
    <bullet> CDC and ATSDR will not fund 100 percent of any conference 
proposed under this announcement. Part of the cost of the proposed 
conference must be supported with funds other than Federal funds.
    <bullet> CDC and ATSDR will not fund a conference after it has 
taken place.
    <bullet> Federal funds may not be used to fund novelty items or 
souvenirs.
    Guidance for completing your budget can be found on the CDC Web 
site, at the following Internet address: http://www.cdc.gov/od/pgo/funding/budgetguide.htm.

IV.6. Other Submission Requirements

    LOI and Application Submission Address: Submit your original and 
two hard copies of LOI and application by express mail or delivery 
service to: Technical Information Management Section, PA 05002, 
Procurement and Grants Office, Centers for Disease Control and 
Prevention, 2920 Brandywine Road, Room 3000, Atlanta, Georgia 30341-
4146. LOIs and applications may not be submitted electronically at this 
time.

V. Application Review Information

V.1. Criteria

    Applicants are required to provide measures of effectiveness that 
will demonstrate the accomplishment of the various identified 
objectives of the grant. Measures of effectiveness must relate to the 
performance goals stated in the ``Purpose'' section of this 
announcement. Measures must be objective and quantitative, and must 
measure the intended outcome. These measures of effectiveness must be 
submitted with the application and will be an element of evaluation.
    Each application will be evaluated individually against the 
following criteria by an independent review group appointed by CDC.

Section 1.a., is ATSDR specific
Section 1.b., is CDC specific
Section 1.c., and all other sections in these criteria are applicable 
to both CDC and ATSDR. Each application will be evaluated based on the 
following criteria:
1. Proposed Program and Technical Approach (25 Points)
    a. The public health significance of the proposed conference, 
including the degree to which the conference can be expected to 
influence the prevention of exposure and adverse human health effects 
and diminished quality of life associated with exposure to hazardous 
substances from waste sites, unplanned releases and other sources of 
pollution present in the environment (Applicable to ATSDR applications 
only).
    b. The applicant's description of the proposed conference as it 
relates to specific non-Federal conferences in the areas of health 
promotion and disease prevention information/education programs (except 
substance abuse), including the public health need of the proposed 
conference and the degree to which the conference can be expected to 
influence public health practices. Evaluation will also be based on the 
extent of the applicant's collaboration with other organizations 
serving the intended audience (Applicable to all CDC applications 
except ATSDR).
    c. The applicant's description of conference objectives in terms of 
quality, specificity, and the feasibility of the conference based on 
the operational plan will also be evaluated.
2. Conference Objectives (25 Points)
    a. The overall quality, reasonableness, feasibility, and logic of 
the designed conference objectives, including the overall work plan and 
timetable are accomplished.
    b. The likelihood of accomplishing conference objectives as they 
relate to disease prevention and health promotion goals, and the 
feasibility of the project in terms of the operational plan.
3. The Qualifications of Program Personnel (20 Points)
    Evaluation will be based on the extent to which the application has 
described:
    a. The extent to which the application provides evidence of the 
qualifications, experience, and commitment of the principal staff 
person, and his/her ability to devote adequate time and effort to 
provide effective leadership.
    b. The extent to which the application provides evidence of the 
competence of associate staff persons, discussion leaders, speakers, 
and presenters to accomplish conference objectives.
    c. The extent to which the application demonstrates the knowledge 
of nationwide and educational efforts currently underway which may 
affect, and be affected by, the proposed conference.
4. Evaluation Methods (20 Points)
    Evaluation instrument(s) for the conference should adequately 
assess increased knowledge, attitudes, and behaviors of the target 
audience.
5. Applicant's Capability (10 Points)
    a. The applicant's capability includes the adequacy of the 
applicant's resources (additional sources of funding, organization's 
strengths, staff time, proposed physical facilities, etc.) available 
for conducting conference activities.
    b. The extent to which the applicant demonstrates a history (at 
least three years) of managing conferences.
6. Budget Justification and Adequacy of Facilities (Not Scored)
    The proposed budget will be evaluated on the basis of its 
reasonableness, concise and clear justification, and consistent with 
the intended use of grant funds. The application will also be reviewed 
as to the adequacy of existing or proposed facilities and resources for 
conducting conference activities.

V.2. Review and Selection Process

    Applications will be reviewed for completeness by the Procurement 
and Grants Office (PGO) staff, and for responsiveness by the relevant 
CIO. Incomplete applications and applications that are non-responsive 
to the eligibility criteria will not advance through the review 
process. Applicants will be notified that their application did not 
meet submission requirements.
    An objective review panel consisting of CDC members outside the 
funding center will evaluate complete and responsive applications 
according to the criteria listed in the ``V.1. Criteria'' section 
above. Three reviewers from CDC staff that are not employees of the 
cognizant center will review and present their findings to the panel. 
The panel votes to approve or disapprove

[[Page 63546]]

based on this information and each application is scored and ranked.
    In addition, the following factors may affect the funding decision:
    <bullet> Availability of funds
    <bullet> Relevance to program priorities.
    Applications will be funded in order by score and rank determined 
by the review panel. CDC/ATSDR will provide justification for any 
decision to fund out of rank order.

V.3. Anticipated Announcement and Award Dates

    The anticipated announcement date is November 1, 2004 and the award 
dates will be 30-60 days before the conferences begin.

VI. Award Administration Information

VI.1. Award Notices

    Successful applicants will receive a Notice of Grant Award (NGA) 
from the CDC Procurement and Grants Office. The NGA shall be the only 
binding, authorizing document between the recipient and CDC. The NGA 
will be signed by an authorized Grants Management Officer, and mailed 
to the recipient fiscal officer identified in the application.
    Unsuccessful applicants will receive notification of the results of 
the application review by mail.

VI.2. Administrative and National Policy Requirements

    45 CFR part 74 and part 92.
    For more information on the Code of Federal Regulations, see the 
National Archives and Records Administration at the following Internet 
address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html.
    The following additional requirements apply to this project:
    <bullet> AR-7 Executive Order 12372.
    <bullet> AR-9 Paperwork Reduction Act Requirements.
    <bullet> AR-10 Smoke-Free Workplace Requirements.
    <bullet> AR-11 Healthy People 2010.
    <bullet> AR-12 Lobbying Restrictions.
    <bullet> AR-13 Prohibition on Use of CDC Funds for Certain Gun 
Control Activities.
    <bullet> AR-15 Proof of Non-Profit Status.
    <bullet> AR-20 Conference Support.
    Additional information on these requirements can be found on the 
CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/ARs.htm.

VI.3. Reporting Requirements

    You must provide CDC with an original, plus two hard copies of the 
following reports:
    1. Interim progress report, due no less than 90 days before the end 
of the budget period.
    2. Financial status report, due no later than 90 days after the end 
of the budget period/project.
    These reports must be mailed to the Grants Management or Contract 
Specialist listed in the ``Agency Contacts'' section of this 
announcement.

VII. Agency Contacts

    We encourage inquiries concerning this announcement.
    For general questions, contact: Technical Information Management 
Section, CDC Procurement and Grants Office, 2920 Brandywine Road, 
Atlanta, GA 30341, telephone: 770-488-2700.
    For program technical assistance, contact: Refer to the Attachment 
for contacts listed per each center.
    For business management assistance, contact: Edna Green, Grants 
Management Specialist, CDC Procurement and Grants Office, 2920 
Brandywine Road, Atlanta, GA 30341, telephone: 770-488-2743. e-mail: 
<a href="/cdn-cgi/l/email-protection#91f4f6e3f4f4ffd1f2f5f2bff6fee7"><span class="__cf_email__" data-cfemail="dcb9bbaeb9b9b29cbfb8bff2bbb3aa">[email protected]</span></a>.

VIII. Other Information

    This and other CDC funding opportunity announcements can be found 
on the CDC Web site, Internet address: http://www.cdc.gov. Click on 
``Funding'' then ``Grants and Cooperative Agreements.''

    Dated: October 27, 2004.
William P. Nichols,
Acting Director, Procurement and Grants Office, Centers for Disease 
Control and Prevention.

Attachment

Topic Areas of Programmatic Interest and Contact Information

100. Agency for Toxic Substances and Disease Registry (ATSDR)--
LaShonda Billingsley, (404) 498-0275, <a href="/cdn-cgi/l/email-protection#86cac4efeaeaefe8e1f5eae3ffc6e5e2e5a8e1e9f0"><span class="__cf_email__" data-cfemail="2d616f44414144434a5e4148546d4e494e034a425b">[email protected]</span></a>.
100.1 Health effects of hazardous substances in the environment;
100.2 Disease and toxic substance exposure registries;
100.3 Hazardous substance removal and remediation;
100.4 Emergency Response to toxic and environmental disasters;
100.5 Risk communication;
100.6 Environmental Disease Surveillance;
100.7 Investigation and research on hazardous substances in the 
environment
300. National Center on Birth Defects and Developmental Disabilities 
(NCBDDD)--Sheryl Heard, (404) 498-3978, <a href="/cdn-cgi/l/email-protection#a6f5eec3c7d4c2e6c5c2c588c1c9d0"><span class="__cf_email__" data-cfemail="1c4f54797d6e785c7f787f327b736a">[email protected]</span></a>.
300.1 Birth Defects
300.2 Fetal Alcohol Syndrome
300.3 Disabilities: Issues related to people with disabilities; 
health promotion and intervention for persons with disabilities; 
secondary conditions; and aging and disability;
300.4 Newborn and Childhood screening: Hearing, metabolic, genetic, 
and developmental
300.5 Hearing Loss, early interventions, genetic causes
300.6 Mental Retardation
300.7 Child Development
300.8 Autism Spectrum Disorders and Other Developmental Disabilities
300.9 Hereditary Blood Disorders
500. National Center for Environmental Health (NCEH)--LaShona 
Billingsley, (404) 498-0275, <a href="/cdn-cgi/l/email-protection#733f311a1f1f1a1d14001f160a331017105d141c05"><span class="__cf_email__" data-cfemail="95d9d7fcf9f9fcfbf2e6f9f0ecd5f6f1f6bbf2fae3">[email protected]</span></a>.
500.1 Genetics and Disease Prevention
500.2 Emergency and Environmental Health Services (lead poisoning, 
environmental health hazards)
500.3 Environmental Hazards and Health Effects (air pollution, 
asthma, health studies)
500.4 Division of Laboratory Sciences (air toxins, newborn 
screening)
600. National Center HIV, STD, and TB Prevention (NCHSTP)--Beth 
Wolfe, (404) 639-8531, <a href="/cdn-cgi/l/email-protection#6220350d0e0407220106014c050d14"><span class="__cf_email__" data-cfemail="88cadfe7e4eeedc8ebeceba6efe7fe">[email protected]</span></a>.
600.1 Sexually Transmitted Diseases (not HIV)
600.2 Tuberculosis in Foreign Born Persons in the United States
600.3 Tuberculosis in African American Populations in the United 
States (especially in the Southeast)
600.4 Therapeutics and Diagnostics
800.0 National Center for Injury Prevention and Control (NCIPC)--
Benjamin Moore, (770) 488-4710, <a href="/cdn-cgi/l/email-protection#8cc1e3e3fee9ccefe8efa2ebe3fa"><span class="__cf_email__" data-cfemail="3b765454495e7b585f58155c544d">[email protected]</span></a>.
800.1 Unintentional Injuries Prevention
800.2.1 National level conferences that focus on preventing child 
maltreatment before it occurs (primary prevention)
800.2.2 National level conferences that focus on preventing youth 
violence before it occurs (primary prevention)
800.3 Acute Injury Care
800.4 Traumatic Brain Injury (TBI)
800.5 Injury Related Disability
800.6 Preparedness and Response for Injuries Resulting from Mass 
Causality Events and/or Terrorist Attacks
800.7 Impact Biomechanics
1500. Public Health Practice Program Office (PHPPO)--Janet Telman, 
(770) 488-2834, <a href="/cdn-cgi/l/email-protection#317b65545d5c505f715255521f565e47"><span class="__cf_email__" data-cfemail="81cbd5e4edece0efc1e2e5e2afe6eef7">[email protected]</span></a>.
1500.1 Laboratory Practice
1500.2 Training and Materials

[FR Doc. 04-24390 Filed 11-1-04; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>